Mangiferin ameliorates 6-hydroxydopamine induced cytotoxicity and oxidative stress in ketamine model of schizophrenia

Pharmacological Reports

Volumn 64, Issue 4, 2012, Pages 848-856

  Rao, Vietla S ^a   Carvalho, Ana C ^a   Trevisan, Maria Teresa S ^a   Andrade, Geanne M ^a   Nobre, Helio V ^a   Moraes, Manoel O ^a   Iury, Hemerson I Magalhães H ^a   Morais, Talita C ^a   Santos, Flavia A ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

6 OHDA; Cytoprotection; Ketamine; Mangiferin; Mesencephalic cell culture; Oxidative stress

Indexed keywords

ACRIDINE ORANGE; ETHIDIUM BROMIDE; INTERLEUKIN 6; KETAMINE; MALONALDEHYDE; MANGIFERIN; OXIDOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BEHAVIOR CHANGE; BRAIN TISSUE; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INTERLEUKIN 6 TISSUE LEVEL; LIPID PEROXIDATION; LOCOMOTION; MALE; MALONALDEHYDE TISSUE LEVEL; MESENCEPHALON; MOTOR DYSFUNCTION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; RAT; REARING; SCHIZOPHRENIA; STEREOTYPY; TISSUE LEVEL; TREATMENT DURATION;

EID: 84867672917     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(12)70879-4     Document Type: Article

References (46)

1. Adibhatla RM, Hatcher JF: Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal, 2010, 12, 125-169.
2. Amazzal L, Lapôtre A, Quignon F, Bagrel D: Mangiferin protects against 1-methyl-4-phenylpyridinium toxicity mediated by oxidative stress in N2A cells. Neurosci Lett, 2007, 418, 159-164. (Pubitemid 46636006)
3. Andreu GL, Delgado R, Velho J, Curti C, Vercesi AE: Iron complexing activity of mangiferin, a naturally occurring glucosylxanthone, inhibits mitochondrial lipid peroxidation induced by Fe2+-citrate. Eur J Pharmacol, 2005, 513, 47-55. (Pubitemid 40692245)
4. Barreto JC, Trevisan MT, Hull WE, Erben G, de Brito ES, Pfundstein B, Würtele G et al.: Characterization and quantitation of polyphenolic compounds in bark, kernel, leaves, and peel of mango (Mangifera indica L.). J Agric Food Chem, 2008, 56, 5599-5610.
5. Becker A, Peters B, Schroeder H, Mann T, Huether G, Grecksch G: Ketamine-induced changes in rat behavior: A possible animal model of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry, 2003, 27, 687-700. (Pubitemid 36645072)
6. Beraki S, Kuzmin A, Tai F, Ogren SO: Repeated low dose of phencyclidine administration impairs spatial learning in mice: blockade by clozapine but not by haloperidol. Eur Neuropsychopharmacol, 2008, 18, 4869-4877.
7. Behrens MM, Ali SS, Dugan LL: Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. J Neurosci, 2008, 28, 13957-13966.
8. Bubeníková-Valesová V, Horácek J, Vrajová M, Höschl C: Models of schizophrenia in humans and animals based on inhibition of NMDA receptors. Neurosci Biobehav Rev, 2008, 32, 1014-1023.
9. Campos-Esparza MR, Sánchez-Gómez MV, Matute C: Molecular mechanisms of neuroprotection by two natural antioxidant polyphenols. Cell Calcium, 2009, 45, 358-368.
10. Carvalho AC, Guedes MM, de Souza AL, Trevisan MT, Lima AF, Santos FA, Rao VS: Gastroprotective effect of mangiferin, a xanthonoid from Mangifera indica, against gastric injury induced by ethanol and indomethacin in rodents. Planta Med, 2007, 73, 1372-1376. (Pubitemid 350084455)
11. Choi DW, Maulucci-Gedde MA, Kreigstein AR. Glutamate neurotoxicity in cortical cell culture. J Neurosci, 1987, 7, 357-368. (Pubitemid 17017465)
12. +-induced dopaminergic neuronal cell death: role of caspasses, ROS, and JNK. J Neurosci Res, 1999, 57, 86-94.
13. Dar A, Faizi S, Naqvi S, Roome T, Zikr-ur-Rehman S, Ali M, Firdous S, Moin ST: Analgesic and antioxidant activity of mangiferin and its derivatives: the structure activity relationship. Biol Pharm Bull, 2005, 28, 596-600. (Pubitemid 40879921)
14. de Oliveira L, Fraga DB, De Luca RD, Canever L, Ghedim FV, Matos MP, Streck EL et al.: Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine. Metab Brain Dis, 2011, 26, 69-77.
15. de Oliveira L, Spiazzi CM, Bortolin T, Canever L, Petronilho F, Mina FG, Dal-Pizzol F et al.: Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats. Prog Neuropsychopharmacol Biol Psychiatry, 2009, 33, 1003-1008.
16. El-Seedi HR, El-Barbary MA, El-Ghorab DM, Bohlin L, Borg-Karlson AK, Göransson U, Verpoorte R: Recent insights into the biosynthesis and biological activities of natural xanthones. Curr Med Chem, 2010, 17, 854-901.
17. Gama CS, Salvador M, Andreazza AC, Lobato MI, Berk M, Kapczinski F, Belmonte-de-Abreu PS: Elevated serum thiobarbituric acid reactive substances in clinically symptomatic schizophrenic males. Neurosci Lett, 2008, 433, 270-273.
18. Glinka Y, Gassen M, Youdim MB: Mechanism of 6-hydroxydopamine neurotoxicity. J Neural Transm Suppl, 1997, 50, 55-56.
19. Green LC, Tanzenbaum SR, Goldman P: Nitrate synthesis in the germ free and conventional rat. Science, 1981, 212, 56-58. (Pubitemid 11114678)
20. Guha S, Ghosal S, Chattopadhyay U: Antitumor, immunomodulatory and anti-HIV effect of mangiferin, a naturally occurring glucosylxanthone. Chemotherapy, 1996, 42, 443-451. (Pubitemid 26379933)
21. Gunduz-Bruce H: The acute effects of NMDA antagonism: from the rodent to the human brain. Brain Res Rev, 2009, 60, 2798-2806.
22. Hetem LA, Danion JM, Diemunsch P, Brandt C: Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers. Psychopharmacology (Berl), 2000, 152, 283-288.
23. Jung K, Lee B, Han SJ, Ryu JH, Kim DH: Mangiferin ameliorates scopolamine-induced learning deficits in mice. Biol Pharm Bull, 2009, 32, 242-246.
24. 2 receptors - implications for models of schizophrenia. Mol Psychiatry, 2002, 7, 837-844.
25. Lakhan SE, Vieira K: Schizophrenia pathophysiology: are we any closer to a complete model? Ann Gen Psychiatry, 2009, 8, 12.
26. Leiro JM, Alvarez E, Arranz JA, Siso IG, Orallo F: In vitro effects of mangiferin on superoxide concentrations and expression of the inducible nitric oxide synthase, tumour necrosis factor-α and transforming growth factor-β genes. Biochem Pharmacol, 2003, 65, 1361-1371. (Pubitemid 36407787)
27. Lemus-Molina Y, Sánchez-Gómez MV, Delgado- Hernández R, Matute C: Mangifera indica L. extract attenuates glutamate-induced neurotoxicity on rat cortical neurons. Neurotoxicology, 2009, 30, 1053-1058.
28. Liu WL, Bian S-Z, Gu Z-L, Jiang X-G, Guo C-Y, Zhao Y-B: Behavior study of ketamine-induced symptoms similar to schizophrenia in mice. J Forensic Med, 2009, 25, 172-175.
29. Mahmood D, Khanam R, Pillai KK, Akhtar M: Reversal of oxidative stress by histamine H3 receptor-ligands in experimental models of schizophrenia. Arzneimittelforschung, 2012, 62, 222-229.
30. Mahmood D, Khanam R, Pillai KK, Akhtar M: Protective effects of histamine H3-receptor ligands in schizophrenic behaviors in experimental models. Pharmacol Rep, 2012, 64, 191-204.
31. Mandryk M, Fidecka S, Poleszak E, Malec D: Participation of adenosine system in the ketamine-induced motor activity in mice. Pharmacol Rep, 2005, 57, 55-60. (Pubitemid 40601541)
32. Márquez L, García-Bueno B, Madrigal JL, Leza JC: Mangiferin decreases inflammation and oxidative damage in rat brain after stress. Eur J Nutr, 2012, 51, 729-739.
33. Martínez Sánchez G, Candelario-Jalil E, Giuliani A, León OS, Sam S, Delgado R, Núñez Sellés AJ: Mangifera indica L. extract (QF808) reduces ischaemia-induced neuronal loss and oxidative damage in the gerbil brain. Free Radic Res, 2001, 35, 465-473.
34. McGohan AJ, Martin SJ, Bissonnette RP, Mahboubi A, Shi Y, Mogil RJ, Nishioka WK, Green DR: The end of the (cell) line: methods for the study of apoptosis in vitro. Methods Cell Biol, 1995, 46, 153-185.
35. Moghaddam B. Recent basic findings in support of excitatory amino acid hypotheses of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry, 1994, 18, 859-870. (Pubitemid 24234869)
36. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol Methods, 1983, 65, 5-63.
37. Nobre Júnior HV, Cunha GM, Maia FD, Oliveira RA, Moraes MO, Rao VS: Catechin attenuates 6-hydroxydopamine (6-OHDA)-induced cell death in primary cultures of mesencephalic cells. Comp Biochem Physiol C Toxicol Pharmacol, 2003, 136, 175-180. (Pubitemid 37237552)
38. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem, 1979, 95, 351-358. (Pubitemid 9194347)
39. Pardo Andreu GL, Maurmann N, Reolon GK, de Farias CB, Schwartsmann G, Delgado R, Roesler R: Mangiferin, a naturally occurring glucoxilxanthone improves long-term object recognition memory in rats. Eur J Pharmacol, 2010, 635, 124-128.
40. Renvoize C, Biola A, Pallardy M, Breard J: Apoptosis: identification of dying cells. Cell Biol Toxicol, 1998, 14, 111-120. (Pubitemid 28123601)
41. Setler P, Sarau H, McKinzie G: Differential attenuation of some effects of haloperidol in rats given scopalamine. Eur J Pharmacol, 1976, 39, 117-126.
42. Singh S, Kumar S, Dikshit M: Involvement of the mitochondrial apoptotic pathway and nitric oxide synthase in dopaminergic neuronal death induced by 6-hydroxydopamine and lipopolysaccharide. Redox Rep, 2010, 15, 115-122.
43. Tsai G, van Kammen DP, Chen S, Kelley ME, Grier A, Coyle JT: Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia. Biol Psychiatry, 1998, 44, 667-674. (Pubitemid 28496781)
44. Wauthoz N, Balde A, Balde ES, Van Damme M, Duez P: Ethnopharmacology of Mangifera indica L. Bark and pharmacological studies of its main C-glucosylxanthone, mangiferin, Int J Biomed Pharm Sci, 2007, 1, 112-119.
45. Yoshikawa M, Ninomiya K, Shimoda H, Nishida N, Matsuda H: Hepatoprotective and antioxidative properties of Salacia reticulata: preventive effects of phenolic constituents on CCl4-induced liver injury in mice. Biol Pharm Bull, 2002, 25, 72-76.
46. Zhang ZJ, Cheang LC, Wang MW, Lee SM: Quercetin exerts a neuroprotective effect through inhibition of the iNOS/NO system and pro-inflammation gene expression in PC12 cells and in zebrafish. Int J Mol Med, 2011, 27, 195-203.